6-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyl (2alpha,3beta,4alpha,6beta)-2,3,6,23-tetrahydroxyurs-12-en-28-oate

Details

Top
Internal ID e2cbdd3f-97a8-405e-99db-6f27b28b53f3
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Terpene glycosides > Triterpene glycosides > Triterpene saponins
IUPAC Name [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] (1S,2R,4aS,6aR,6aS,6bR,8R,8aR,9R,10R,11R,12aR,14bS)-8,10,11-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylate
SMILES (Canonical) CC1CCC2(CCC3(C(=CCC4C3(CC(C5C4(CC(C(C5(C)CO)O)O)C)O)C)C2C1C)C)C(=O)OC6C(C(C(C(O6)COC7C(C(C(C(O7)CO)O)O)O)O)O)O
SMILES (Isomeric) C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(C[C@H]([C@@H]5[C@@]4(C[C@H]([C@@H]([C@@]5(C)CO)O)O)C)O)C)[C@@H]2[C@H]1C)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O)O
InChI InChI=1S/C42H68O16/c1-18-9-10-42(37(54)58-36-32(52)30(50)28(48)24(57-36)16-55-35-31(51)29(49)27(47)23(15-43)56-35)12-11-40(5)20(26(42)19(18)2)7-8-25-38(3)13-22(46)34(53)39(4,17-44)33(38)21(45)14-41(25,40)6/h7,18-19,21-36,43-53H,8-17H2,1-6H3/t18-,19+,21-,22-,23-,24-,25-,26+,27-,28-,29+,30+,31-,32-,33-,34+,35-,36+,38-,39+,40-,41-,42+/m1/s1
InChI Key JSQCMNXZFPMWES-WRBXKWMASA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C42H68O16
Molecular Weight 829.00 g/mol
Exact Mass 828.45073608 g/mol
Topological Polar Surface Area (TPSA) 277.00 Ų
XlogP 0.40
Atomic LogP (AlogP) -0.91
H-Bond Acceptor 16
H-Bond Donor 11
Rotatable Bonds 7

Synonyms

Top
386223-75-2
6-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyl (2alpha,3beta,4alpha,6beta)-2,3,6,23-tetrahydroxyurs-12-en-28-oate

2D Structure

Top
2D Structure of 6-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyl (2alpha,3beta,4alpha,6beta)-2,3,6,23-tetrahydroxyurs-12-en-28-oate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7336 73.36%
Caco-2 - 0.8891 88.91%
Blood Brain Barrier - 0.6500 65.00%
Human oral bioavailability - 0.7571 75.71%
Subcellular localzation Mitochondria 0.8246 82.46%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8864 88.64%
OATP1B3 inhibitior - 0.4366 43.66%
MATE1 inhibitior - 0.9200 92.00%
OCT2 inhibitior - 0.6526 65.26%
BSEP inhibitior - 0.4705 47.05%
P-glycoprotein inhibitior + 0.7300 73.00%
P-glycoprotein substrate - 0.5322 53.22%
CYP3A4 substrate + 0.7186 71.86%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8587 85.87%
CYP3A4 inhibition - 0.9357 93.57%
CYP2C9 inhibition - 0.9347 93.47%
CYP2C19 inhibition - 0.9271 92.71%
CYP2D6 inhibition - 0.9492 94.92%
CYP1A2 inhibition - 0.9046 90.46%
CYP2C8 inhibition + 0.7139 71.39%
CYP inhibitory promiscuity - 0.9709 97.09%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.6290 62.90%
Eye corrosion - 0.9906 99.06%
Eye irritation - 0.9112 91.12%
Skin irritation - 0.5531 55.31%
Skin corrosion - 0.9498 94.98%
Ames mutagenesis - 0.8400 84.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7086 70.86%
Micronuclear - 0.8600 86.00%
Hepatotoxicity - 0.7875 78.75%
skin sensitisation - 0.9157 91.57%
Respiratory toxicity - 0.5556 55.56%
Reproductive toxicity + 0.9222 92.22%
Mitochondrial toxicity - 0.6375 63.75%
Nephrotoxicity - 0.6774 67.74%
Acute Oral Toxicity (c) III 0.6947 69.47%
Estrogen receptor binding + 0.7807 78.07%
Androgen receptor binding + 0.7548 75.48%
Thyroid receptor binding - 0.5978 59.78%
Glucocorticoid receptor binding + 0.6538 65.38%
Aromatase binding + 0.6406 64.06%
PPAR gamma + 0.7552 75.52%
Honey bee toxicity - 0.7151 71.51%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity - 0.6350 63.50%
Fish aquatic toxicity + 0.9206 92.06%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.12% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 97.15% 96.09%
CHEMBL3137262 O60341 LSD1/CoREST complex 95.72% 97.09%
CHEMBL253 P34972 Cannabinoid CB2 receptor 93.68% 97.25%
CHEMBL226 P30542 Adenosine A1 receptor 91.20% 95.93%
CHEMBL2581 P07339 Cathepsin D 90.29% 98.95%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 89.79% 95.56%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 88.47% 94.45%
CHEMBL1994 P08235 Mineralocorticoid receptor 87.28% 100.00%
CHEMBL1293249 Q13887 Kruppel-like factor 5 86.84% 86.33%
CHEMBL4016 P42262 Glutamate receptor ionotropic, AMPA 2 85.55% 86.92%
CHEMBL5255 O00206 Toll-like receptor 4 85.48% 92.50%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 84.50% 95.50%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 82.95% 96.77%
CHEMBL3880 P07900 Heat shock protein HSP 90-alpha 82.59% 96.21%
CHEMBL3476 O15111 Inhibitor of nuclear factor kappa B kinase alpha subunit 81.56% 95.83%
CHEMBL3714130 P46095 G-protein coupled receptor 6 81.24% 97.36%
CHEMBL218 P21554 Cannabinoid CB1 receptor 80.73% 96.61%

Cross-Links

Top
PubChem 101140416
NPASS NPC258892
LOTUS LTS0233090
wikiData Q105134527